Search Results - S. V. Turkina

The study included 60 patients, aged 45-65 years, with Functional Class II-III chronic heart failure (CHF) in early post-infarction period and Type 2 diabetes mellitus (DM-2). The participants were randomised into two groups (n=30 for each group). In the main group, Mexicor (0,4 g/d) was added to th...

Full description

In total, 60 45-70-year-old patients with Functional Class II-III chronic heart failure (CHF) after a myocardial infarction, compensated or sub-compensated Type 2 diabetes mellitus (DM-2), and autonomous cardiac neuropathy were examined. The basis therapy included enalapril, bisoprolol, aspirin, and...

Full description

.

In total, the study included 60 45-64-year-old patients in early post-infarction phase, with chronic heart failure (CHF), Functional Class II-III, and metabolic syndrome (MS). The patients were randomised into two groups (n=30 in each group). In the main group, standard CHF therapy was extended by a...

Full description

.

High prevalence of chronic heart failure (CHF) and type 2 diabetes (DM2), poor prognosis and low life quality determine the aim for optimum treatment strategy invention. Cornerstone of the treatment in this category of patients is correction of endothelial dysfunction and metabolism disorders that u...

Full description

The study included 60 patients, aged 45-65 years, with metabolic syndrome (MS), Functional Class II-III chronic heart failure (CHF), and recent myocardial infarction (MI). The participants were randomised into 2 groups (n=30 in each). The main group received standard CHF therapy and Mexicor (0,4 g/d...

Full description

In total, 100 patients aged 45-70 years, with Functional Class (FC) II-III chronic heart failure (CHF) and compensated or sub-compensated Type 2 diabetes mellitus (DM-2) were examined. All participants were randomised into two groups, including 50 individuals each. In the main group, the standard CH...

Full description

This 12-week study included 60 patients (age 45-65 years) with metabolic syndrome (MS), chronic heart failure (CHF) of II-III functional class (FC), and recent myocardial infarction. The participants were randomised into two groups (n=30 for each). In the main group, standard CHF therapy was combine...

Full description

The study aimed to assess the effects of long-term and course mildronate therapy (500 mg/d) on cognitive function in elderly patients with arterial hypertension (AH) and cognitive dysfunction. This open, randomised, controlled comparative study in parallel groups (long-term therapy for 52 weeks, or...

Full description

Aim. To assess the effect of meldonium (in combination with antihypertensive therapy) on the severity of asthenic syndrome (AS) in elderly patients with arterial hypertension (HT).Material and methods. Patients (n=180, >65 years old) with HT (grade 1–2) and secondary somatogenic AS (assessed...

Full description

Aim. To assess the effects of the “interval” (3 months of treatment, followed by treatment-free 3 months) and “persistent” (52 weeks) therapy with Mildronate (500 mg/d) in elderly patients with arterial hypertension (AH) and cognitive dysfunction. Material and methods. In total, 1800 elderly patient...

Full description

Aim. The clinical guidelines are intended to provide information support for making decisions by gastroenterologists, general practitioners and internists that will improve the quality of medical care for patients with non-alcoholic fatty liver disease, taking into account the latest clinical data a...

Full description